A Tenenbaum, M Motro, EZ Fisman - Cardiovascular Diabetology, 2005 - biomedcentral.com There are three peroxisome proliferator-activated receptors (PPARs) subtypes
which are commonly designated PPAR alpha, PPAR gamma and PPAR beta/delta. PPAR
alpha activation increases high density lipoprotein (HDL) cholesterol ... Cited by 94 - Related articles - Cached - All 13 versions
- ►daegu.ac.kr [PDF] S Kersten - European journal of pharmacology, 2002 - Elsevier The peroxisome proliferator activated receptors (PPARs) are a group of
ligand-activated transcription factors that govern numerous biological
processes, including energy metabolism, cell proliferation, and ... Cited by 86 - Related articles - All 7 versions
- ►shouxi.net MJ Yoon, GY Lee, JJ Chung, YH Ahn, SH … - Diabetes, 2006 - Am Diabetes Assoc Adiponectin has recently received a great deal of attention due to its
beneficial effects on insulin resistance and metabolic disorders. One of the
mechanisms through which adiponectin exerts such effects involves an ... Cited by 83 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org M Laplante, H Sell, KL MacNaul, D Richard, … - Diabetes, 2003 - Am Diabetes Assoc This study sought to determine whether the adipose depot−specific
(subcutaneous [SF] vs. visceral [VF]) action of peroxisome
proliferator−activated receptor-γ (PPAR-γ) agonists on fat deposition ... Cited by 77 - Related articles - BL Direct - All 5 versions
P Flachs, O Horakova, P Brauner, M Rossmeisl … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 2365–2375 DOI 10.1007/s00125-005-1944-7 ARTICLE
P. Flachs . O. Horakova . P. Brauner . M. Rossmeisl . P. Pecina . ... Cited by 54 - Related articles - BL Direct - All 5 versions
JM Peters, T Aoyama, AM Burns, FJ Gonzalez - BBA-Molecular and Cell Biology of Lipids, 2003 - Elsevier Bezafibrate is a known activator of peroxisome proliferator-activated receptors
(PPARs) that can activate both PPARα and PPARβ. To determine the role(s) of
these receptors in mediating the biological effects of this chemical, the ... Cited by 54 - Related articles - All 5 versions
- ►jbc.org A Planavila, JC Laguna, M Vazquez-Carrera - Journal of Biological Chemistry, 2005 - ASBMB Little is known about the mechanisms responsible for the fall in fatty acid
oxidation during the development of cardiac hypertrophy. We focused on the
effects of nuclear factor (NF)- B activation during cardiac hypertrophy on ... Cited by 49 - Related articles - All 5 versions
- ►natureblink.com [PDF] O Matejkova, KJ Mustard, J Sponarova, P … - FEBS letters, 2004 - Elsevier The AMP-activated protein kinase (AMPK) cascade is a sensor of cellular energy
charge that promotes catabolic and inhibits anabolic pathways. However, the role
of AMPK in adipocytes is poorly understood. We show that transgenic ... Cited by 38 - Related articles - All 11 versions
- ►nih.gov J Xu, P Wang, Y Li, G Li, LK Kaczmarek, Y Wu, … - Proceedings of the National Academy of Sciences of …, 2004 - National Acad Sciences Kv1.3 is a voltage-gated potassium (K) channel expressed in a number of tissues,
including fat and skeletal muscle. Channel inhibition improves experimental
autoimmune encephalitis, in part by reducing IL-2 and tumor necrosis factor ... Cited by 37 - Related articles - BL Direct - All 12 versions
A Planavila, JC Laguna, M Vázquez-Carrera - BBA-Molecular and Cell Biology of Lipids, 2005 - Elsevier Nuclear factor (NF)-κB signaling pathway plays a pivotal role in cardiac
hypertrophy. Although it has been reported that statins inhibit cardiac
hypertrophy by reducing generation of reactive oxygen species, it is not ... Cited by 38 - Related articles - All 3 versions
